Global Molecular Modelling Market, By Product (Software, Services), Approach (Molecular Mechanics Approach, Quantum Chemistry Approach), Application (Drug Development, Drug Discovery, Others), End-User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic Institutions, Others) - Industry Trends and Forecast to 2030.
Molecular Modelling Market Analysis and Size
The increasing research and development activities are escalating the growth of the molecular modelling market. Molecular modelling is a technique utilized for the drug-designing process. It assists in describing the generation or manipulation, three-dimensional structures of molecules and physic-chemical properties. They help in studying the structures and behaviour of molecules. They are also deployed for computational biology and material science. Various computerized techniques are adopted to analyze the biological and molecular properties.
The increasing investment by pharmaceutical and biotechnology companies in research and development is one of the major factors driving the growth of the molecular modelling market. The increasing incidence of diseases such as cancer, cardiovascular disease, and infections and ongoing technological advancement and development accelerate the market growth of the molecular modelling market. The rise in the need to incorporate structural biology and molecular modelling techniques to develop a new generation of drugs and high drug attrition rates associated with late-phase clinical trials in drug development further influence the molecular modelling market. Additionally, the increasing geriatric population, awareness of diseases and treatments among people, research and development activities, enhancing healthcare infrastructure and a surge in healthcare expenditure positively affect the molecular modelling market.
Data Bridge Market Research analyses that the molecular modelling market was valued at USD 3,226.86 million in 2022 and is further estimated to reach USD 9486.34 billion by 2030, and is expected to grow at a CAGR of 14.43% during the forecast period of 2023 to 2030. 'Software' segment in product segment is expected to dominate the market due to increasing research and development activities by key manufacturers. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Molecular Modelling Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product (Software, Services), Approach (Molecular Mechanics Approach, Quantum Chemistry Approach), Application (Drug Development, Drug Discovery, Others), End-User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic Institutions, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Cresset (U.K.), Schrödinger, Inc (U.S.), Optibrium, Ltd. (U.K.), BioSolveIT GmbH (Germany), Simulations Plus (U.S.), Chemical Computing Group ULC (Canada), Certara, USA (U.S.), OpenEye Cadence Molecular Sciences. (U.S.), Dassault Systèmes (France), Thermo Fisher Scientific Inc. (U.S.), Advanced Chemistry Development, Inc. (Canada), Physiomics Plc (U.K.), Genedata AG (Switzerland), Rosa & Co., LLC (U.S.), Bioinformatics Inc. (U.S.), Bruker (U.S.), Labvantage-Biomax GmbH (Germany), and QIAGEN (Germany) among other
|
|
Market Opportunities
|
|
Market Definition
The global molecular modelling market refers to the market of computational techniques and tools used to simulate and visualize the structure and behaviour of molecules. Molecular modelling involves the study of molecular systems at the atomic and molecular level using computer algorithms and simulations to understand their properties and interactions.
Molecular Modelling Market Dynamics
Drivers
- Increasing Drug Discovery and Development
Molecular modelling plays a crucial role in the drug discovery and development process. The growing demand for new and effective drugs has led to the use of molecular Modelling methods. This allows researchers to study molecular structures, predict drug-target interactions and optimize drug candidates, which speeds up the drug development process.
- Advancements in Computational Power
The continuous advancements in computational power and high-performance computing have significantly enhanced the capabilities of molecular modelling. Improved computing resources allow for faster and more accurate simulations, enabling researchers to perform complex calculations and analyze larger molecular systems in a shorter time frame.
- Growing Adoption of Material Science
Molecular Modelling techniques are increasingly used in materials science research. They facilitate the study of materials at the atomic and molecular level, enabling the design and development of advanced materials with desired properties. Molecular modelling helps optimize material structures, predict material behavior and understand molecular interactions, leading to innovations in electronics, energy and aeronautics.
Opportunities
- Expansion in Pharmaceutical and Biotechnology Industries
The pharmaceutical and biotechnology industry is growing rapidly worldwide. The growing focus on personalized medicine, precision therapy and biology is creating opportunities for molecular modelling. These industries can use molecular Modelling tools to design custom drug molecules, predict drug-target interactions, and optimize therapies.
- Rising Demand for Computational Chemistry Services
As molecular modelling techniques become more sophisticated, the demand for specialized computational chemistry services increases. Service providers that offer molecular Modelling expertise, simulations and data analysis are poised to benefit from the market expansion. These services serve pharmaceutical companies, research institutions and other industries looking for computer support for their molecular research.
Restraints/Challenges
- High Cost of Implementation
Applying molecular Modelling techniques and tools can be capital-intensive. Costs include acquiring advanced computing resources, software licenses and professional staff. The high upfront and ongoing costs associated with establishing and maintaining a molecular Modelling infrastructure can be prohibitive for smaller organizations or organizations with limited budgets.
- Validation and Accuracy
Validating and ensuring the accuracy of molecular modelling results can be difficult. Molecular simulations and predictions are based on complex algorithms and approximations, and their accuracy depends on several factors, such as the quality of input data, force fields, and simulation parameters. The challenge is experimentally validating these results and refining the models to improve accuracy, which requires interdisciplinary collaboration and robust experimental validation methods.
This molecular modelling market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the molecular modelling market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May 2021, Dassault Systèmes acquired the scientific informatics software company, Biovia, to expand its capabilities in the life and material sciences domains. The acquisition aimed to strengthen Dassault Systèmes' position in providing end-to-end solutions for scientific research and molecular modelling.
- In April 2021, Accelera Ltd introduced a new version of ACEMD, which is its molecular dynamics simulation software.
- In March 2021, Schrödinger announced a collaboration with AstraZeneca to develop a software platform for accelerating drug discovery using artificial intelligence (AI) and molecular modelling. The platform aims to enhance the speed and efficiency of drug discovery processes.
Global Molecular Modelling Market Scope
The molecular modelling market is segmented on the basis of product, approach, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Software
- Services
Approach
- Molecular mechanics approach
- Quantum chemistry approach
Application
- Drug Development
- Drug Discovery
- Others
End-User
- Pharmaceutical and biotechnology companies
- Research centers and academic institutions
- Others
Molecular Modelling Market Regional Analysis/Insights
The molecular modelling market is analyzed and market size insights and trends are provided by country, product, approach, application, and end-user, as referenced above.
The countries covered in the molecular modelling market report are the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America dominates the molecular modelling market due to the collaborations of prominent market players to increase research and development activities and high medical standards.
Asia-Pacific is the fastest growing during the forecast period of 2023 to 2030 because of the rising presence of contract research organizations, unprecedented evolution of the healthcare infrastructure and standards and surge in healthcare IT spending in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The molecular modelling market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for molecular modelling market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the molecular modelling market. The data is available for historic period 2015-2020.
Competitive Landscape and Molecular Modelling Market Share Analysis
The molecular modelling market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the molecular modelling market are:
- Cresset (U.K.)
- Schrödinger, Inc (U.S.)
- Optibrium, Ltd. (U.K.)
- BioSolveIT GmbH (Germany)
- Simulations Plus (U.S.)
- Chemical Computing Group ULC (Canada)
- Certara, USA (U.S.)
- OpenEye Cadence Molecular Sciences. (U.S.)
- Dassault Systèmes (France)
- Thermo Fisher Scientific Inc. (U.S.)
- Advanced Chemistry Development, Inc. (Canada)
- Physiomics Plc (U.K.)
- Genedata AG (Switzerland)
- Rosa & Co., LLC (U.S.)
- Bioinformatics Inc. (U.S.)
- Bruker (U.S.)
- Labvantage-Biomax GmbH (Germany)
- QIAGEN (Germany)
SKU-